{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:59:14Z","timestamp":1791097154089,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.mcna.2006.06.007","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T14:28:20Z","timestamp":1168439300000},"page":"1049-1076","source":"Crossref","is-referenced-by-count":30,"title":["Antibiotics\u2014Past, Present, and Future"],"prefix":"10.1016","volume":"90","author":[{"given":"Nancy","family":"Khardori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9143","key":"10.1016\/j.mcna.2006.06.007_bib1","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/S0140-6736(05)79939-6","article-title":"5300 years ago, the Ice Man used natural laxatives and antibiotics","volume":"352","author":"Capasso","year":"1998","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.mcna.2006.06.007_bib2","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3810\/pgm.1997.01.139","article-title":"Antibiotics: past, present, and future. Unearthing nature's magic bullets","volume":"101","author":"Hoel","year":"1997","journal-title":"Postgrad Med"},{"key":"10.1016\/j.mcna.2006.06.007_bib3","first-page":"58","article-title":"Alexander Fleming\u2014medicine's accidental hero","year":"1998","journal-title":"US News World Rep"},{"issue":"4","key":"10.1016\/j.mcna.2006.06.007_bib4","doi-asserted-by":"crossref","first-page":"176","DOI":"10.5694\/j.1326-5377.2002.tb04349.x","article-title":"Howard Florey, Alexander Fleming and the fairy tale of penicillin","volume":"176","author":"Goldsworthy","year":"2002","journal-title":"Med J Aust"},{"key":"10.1016\/j.mcna.2006.06.007_bib5","first-page":"645","article-title":"The penicillin saga remembered","volume":"44","author":"Raper","year":"1978","journal-title":"ASM News"},{"issue":"3","key":"10.1016\/j.mcna.2006.06.007_bib6","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4065\/74.3.290","article-title":"Symposium on antimicrobial agents. Part VI. The penicillins","volume":"74","author":"Wright","year":"1999","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.mcna.2006.06.007_bib7","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/clinids\/1.3.434","article-title":"From penicillin-binding proteins to the lysis and death of bacteria: a 1979 view","volume":"1","author":"Tomasz","year":"1979","journal-title":"Rev Infect Dis"},{"issue":"2","key":"10.1016\/j.mcna.2006.06.007_bib8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4065\/74.2.187","article-title":"Symposium on antimicrobial agents. Part V. The cephalosporins","volume":"74","author":"Marshall","year":"1999","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1016\/j.mcna.2006.06.007_bib9","doi-asserted-by":"crossref","first-page":"420","DOI":"10.4065\/74.4.420","article-title":"Symposium on antimicrobial agents. Part VII. Carbapenems and monobactams: imipenem, meropenem, and aztreonam","volume":"74","author":"Hellinger","year":"1999","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"10.1016\/j.mcna.2006.06.007_bib10","doi-asserted-by":"crossref","first-page":"519","DOI":"10.4065\/74.5.519","article-title":"Symposium on antimicrobial agents. Part VIII. The aminoglycosides","volume":"74","author":"Edson","year":"1999","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.mcna.2006.06.007_bib11","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4065\/74.6.613","article-title":"Symposium on antimicrobial agents. Part IX. The macrolides: erythromycin, clarithromycin, and azithromycin","volume":"74","author":"Alvarez-Elcoro","year":"1999","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.mcna.2006.06.007_bib12","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.idc.2004.04.010","article-title":"Macrolides and ketolides: azithromycin, clarithromycin, telithromycin","volume":"18","author":"Zuckerman","year":"2004","journal-title":"Infect\u00a0Dis Clin North Am"},{"issue":"7","key":"10.1016\/j.mcna.2006.06.007_bib13","doi-asserted-by":"crossref","first-page":"727","DOI":"10.4065\/74.7.727","article-title":"Symposium on antimicrobial agents. Part X. The tetracyclines","volume":"74","author":"Smilack","year":"1999","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"10.1016\/j.mcna.2006.06.007_bib14","doi-asserted-by":"crossref","first-page":"825","DOI":"10.4065\/74.8.825","article-title":"Symposium on antimicrobial agents. Part XI. Clindamycin, metronidazole, and chloramphenicol","volume":"74","author":"Kasten","year":"1999","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"10.1016\/j.mcna.2006.06.007_bib15","doi-asserted-by":"crossref","first-page":"730","DOI":"10.4065\/74.7.730","article-title":"Symposium on antimicrobial agents. Part VI. Trimethoprim-sulfamethoxazole","volume":"74","author":"Smilack","year":"1999","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"10.1016\/j.mcna.2006.06.007_bib16","doi-asserted-by":"crossref","first-page":"928","DOI":"10.4065\/74.9.928","article-title":"Symposium on antimicrobial agents. Part XII. Vancomycin","volume":"74","author":"Wilhelm","year":"1999","journal-title":"Mayo Clin Proc"},{"issue":"26","key":"10.1016\/j.mcna.2006.06.007_bib17","first-page":"565","article-title":"Staphylococcus aureus resistant to vancomycin\u2014United States, 2002","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.mcna.2006.06.007_bib18","series-title":"Bennett's principles and practice of infectious diseases","first-page":"417","article-title":"Glycopeptides (vancomycin and teicoplanin), streptogramins (quinupristin-dalfopristin), and lipopeptides (daptomycine)","author":"Murray","year":"2005"},{"issue":"10","key":"10.1016\/j.mcna.2006.06.007_bib19","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.4065\/74.10.1030","article-title":"Symposium on antimicrobial agents. Part XIII. The fluoroquinolones","volume":"74","author":"Walker","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.mcna.2006.06.007_bib20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0196-4399(00)80041-0","article-title":"Quinupristin\/dalfopristin: a novel selective-spectrum antibiotic for the treatment of multi-resistant and other gram-positive pathogens","volume":"21","author":"Nadler","year":"1999","journal-title":"Clin Microbiol Newsl"},{"issue":"1066","key":"10.1016\/j.mcna.2006.06.007_bib21","first-page":"109","article-title":"Quinupristin\/dalfopristin","volume":"41","year":"1999","journal-title":"Med Lett Drugs Ther"},{"issue":"2","key":"10.1016\/j.mcna.2006.06.007_bib22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.7326\/0003-4819-130-2-199901190-00012","article-title":"A novel antimicrobial agent joins the battle against resistant bacteria","volume":"130","author":"Moellering","year":"1999","journal-title":"Ann Intern Med"},{"issue":"1079","key":"10.1016\/j.mcna.2006.06.007_bib23","first-page":"45","article-title":"Linezolid (Zyvox)","volume":"42","year":"2000","journal-title":"Med Lett Drugs Ther"},{"issue":"3","key":"10.1016\/j.mcna.2006.06.007_bib24","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.idc.2004.04.014","article-title":"Antibiotics for gram-positive bacterial infections: vancomycin, quinupristin-dalfopristin, linezolid, and daptomycin","volume":"18","author":"Lundstrom","year":"2004","journal-title":"Infect Dis Clin North Am"},{"issue":"12","key":"10.1016\/j.mcna.2006.06.007_bib25","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1086\/420818","article-title":"The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections","volume":"38","author":"Arbeit","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"1175","key":"10.1016\/j.mcna.2006.06.007_bib26","first-page":"11","article-title":"Daptomycin (Cubicin) for skin and soft tissue infections","volume":"46","year":"2004","journal-title":"Med Lett Drugs Ther"},{"issue":"Suppl 5","key":"10.1016\/j.mcna.2006.06.007_bib27","doi-asserted-by":"crossref","first-page":"S303","DOI":"10.1086\/431672","article-title":"Tigecycline: a new glycylcycline for treatment of serious infections","volume":"41","author":"Noskin","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"Suppl 5","key":"10.1016\/j.mcna.2006.06.007_bib28","doi-asserted-by":"crossref","first-page":"S354","DOI":"10.1086\/431676","article-title":"The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data","volume":"41","author":"Babinchak","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"Suppl 5","key":"10.1016\/j.mcna.2006.06.007_bib29","doi-asserted-by":"crossref","first-page":"S341","DOI":"10.1086\/431675","article-title":"The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam","volume":"41","author":"Ellis-Grosse","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"1217","key":"10.1016\/j.mcna.2006.06.007_bib30","first-page":"73","article-title":"Tigecycline (tygacil)","volume":"47","year":"2005","journal-title":"Med Lett Drugs Ther"},{"issue":"7159","key":"10.1016\/j.mcna.2006.06.007_bib31","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1136\/bmj.317.7159.609","article-title":"Antimicrobial resistance. Is a major threat to public health","volume":"317","author":"Wise","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.mcna.2006.06.007_bib32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/00325481.1947.11691638","article-title":"Treatment of surgical infections by chemical and antibiotic agents","volume":"1","author":"Meleney","year":"1947","journal-title":"Postgrad Med"},{"issue":"9","key":"10.1016\/j.mcna.2006.06.007_bib33","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJM199102283240906","article-title":"New mechanisms of bacterial resistance to antimicrobial agents","volume":"324","author":"Jacoby","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2006.06.007_bib34","series-title":"Jawetz, Melnick, and Adelberg's review of medical microbiology","first-page":"96","article-title":"Microbial genetics","author":"Brooks","year":"2004"},{"issue":"19","key":"10.1016\/j.mcna.2006.06.007_bib35","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJM199611073351907","article-title":"Antimicrobial-drug resistance","volume":"335","author":"Gold","year":"1996","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.mcna.2006.06.007_bib36","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4065\/75.2.200","article-title":"Symposium on antimicrobial agents. Part XVII. Clinical aspects of antimicrobial resistance","volume":"75","author":"Virk","year":"2000","journal-title":"Mayo Clin Proc"},{"issue":"5157","key":"10.1016\/j.mcna.2006.06.007_bib37","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1126\/science.8153624","article-title":"Inactivation of antibiotics and the dissemination of resistance genes","volume":"264","author":"Davies","year":"1994","journal-title":"Science"},{"issue":"7159","key":"10.1016\/j.mcna.2006.06.007_bib38","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/bmj.317.7159.657","article-title":"The origins and molecular basis of antibiotic resistance","volume":"317","author":"Hawkey","year":"1998","journal-title":"BMJ"},{"issue":"7159","key":"10.1016\/j.mcna.2006.06.007_bib39","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1136\/bmj.317.7159.660","article-title":"Antiviral drug resistance","volume":"317","author":"Pillay","year":"1998","journal-title":"BMJ"},{"issue":"5910","key":"10.1016\/j.mcna.2006.06.007_bib40","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/302725a0","article-title":"Conjugative plasmids in bacteria of the \u2018pre-antibiotic\u2019 era","volume":"302","author":"Hughes","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.mcna.2006.06.007_bib41","series-title":"Antibiotic resistance: origins, evolution, selection and spread","first-page":"15","article-title":"Origins, acquisition and dissemination of antibiotic resistance determinants","author":"Davies","year":"1997"},{"issue":"11","key":"10.1016\/j.mcna.2006.06.007_bib42","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1128\/AAC.37.11.2379","article-title":"Antibiotic preparations contain DNA: a source of drug resistance genes?","volume":"37","author":"Webb","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.mcna.2006.06.007_bib43","first-page":"145","article-title":"Antimicrobial therapy: toward the future","volume":"56","author":"Ellis","year":"1996","journal-title":"Br J Hosp Med"},{"issue":"6","key":"10.1016\/j.mcna.2006.06.007_bib44","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMp048093","article-title":"The antibiotic pipeline\u2014challenges, costs, and values","volume":"351","author":"Wenzel","year":"2004","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.mcna.2006.06.007_bib45","doi-asserted-by":"crossref","first-page":"11227","DOI":"10.1073\/pnas.200361997","article-title":"Plasmid-encoded MucB protein is a DNA polymerase (pol RI) specialized for lesion bypass in the presence of MucA\u2032, RecA, and SSB","volume":"97","author":"Goldsmith","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6890","key":"10.1016\/j.mcna.2006.06.007_bib46","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/nature00802","article-title":"Modulation of virulence within a pathogenicity island in vancomycin-resistant Enterococcus faecalis","volume":"417","author":"Shankar","year":"2002","journal-title":"Nature"},{"issue":"5748","key":"10.1016\/j.mcna.2006.06.007_bib47","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1126\/science.1116739","article-title":"Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization","volume":"310","author":"Hung","year":"2005","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.mcna.2006.06.007_bib48","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJMcibr054591","article-title":"Disarming pathogens\u2014a new approach for antibiotic development","volume":"354","author":"Waldor","year":"2006","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.mcna.2006.06.007_bib49","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1128\/AAC.41.2.488","article-title":"In vitro activity and spectrum of LY333328, a novel glycopeptide derivative","volume":"41","author":"Jones","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.mcna.2006.06.007_bib50","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/jac\/33.2.197","article-title":"Dual-action antibiotic hybrids","volume":"33","author":"Hamilton-Miller","year":"1994","journal-title":"J Antimicrob Chemother"},{"issue":"6862","key":"10.1016\/j.mcna.2006.06.007_bib51","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/35106587","article-title":"Innate antimicrobial peptide protects the skin from invasive bacterial infection","volume":"414","author":"Nizet","year":"2001","journal-title":"Nature"},{"issue":"5157","key":"10.1016\/j.mcna.2006.06.007_bib52","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.8153623","article-title":"Ubiquitous natural antibiotics","volume":"264","author":"Gabay","year":"1994","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.mcna.2006.06.007_bib53","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1128\/AEM.68.12.5891-5903.2002","article-title":"Macedocin, a food-grade antibiotic produced by Streptococcus macedonicus ACA-DC 198","volume":"68","author":"Georgalaki","year":"2002","journal-title":"Appl Environ Microbiol"},{"issue":"5594","key":"10.1016\/j.mcna.2006.06.007_bib54","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1126\/science.298.5594.728","article-title":"Bacteriophage therapy. Stalin's forgotten cure","volume":"298","author":"Stone","year":"2002","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.mcna.2006.06.007_bib55","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/scientificamerican0398-46","article-title":"The challenge of antibiotic resistance","volume":"278","author":"Levy","year":"1998","journal-title":"Sci Am"},{"issue":"7159","key":"10.1016\/j.mcna.2006.06.007_bib56","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/bmj.317.7159.645","article-title":"What can be done about resistance to antibiotics?","volume":"317","author":"Turnidge","year":"1998","journal-title":"BMJ"},{"issue":"Suppl 3","key":"10.1016\/j.mcna.2006.06.007_bib57","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1086\/340244","article-title":"Emergence, spread, and environmental effect of antimicrobial resistance: how use of an antimicrobial anywhere can increase resistance to any antimicrobial anywhere else","volume":"34","author":"O'Brien","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"Suppl 3","key":"10.1016\/j.mcna.2006.06.007_bib58","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1086\/340246","article-title":"Antimicrobial use and resistance in animals","volume":"34","author":"McEwen","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"16","key":"10.1016\/j.mcna.2006.06.007_bib59","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1056\/NEJM200110183451610","article-title":"Antimicrobial use in animal feed\u2014time to stop","volume":"345","author":"Gorbach","year":"2001","journal-title":"N Engl J Med"},{"issue":"Suppl 3","key":"10.1016\/j.mcna.2006.06.007_bib60","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1086\/340247","article-title":"Uses of antimicrobials in plant agriculture","volume":"34","author":"Vidaver","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"7159","key":"10.1016\/j.mcna.2006.06.007_bib61","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/bmj.317.7159.647","article-title":"Antimicrobial resistance in developing countries","volume":"317","author":"Hart","year":"1998","journal-title":"BMJ"},{"issue":"23","key":"10.1016\/j.mcna.2006.06.007_bib62","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1001\/jama.287.23.3103","article-title":"Changes in antibiotic prescribing for children after a community-wide campaign","volume":"287","author":"Perz","year":"2002","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.mcna.2006.06.007_bib63","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1001\/jama.287.23.3096","article-title":"Trends in antimicrobial prescribing rates for children and adolescents","volume":"287","author":"McCaig","year":"2002","journal-title":"JAMA"},{"issue":"Suppl 3","key":"10.1016\/j.mcna.2006.06.007_bib64","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1086\/340241","article-title":"Introduction","volume":"34","author":"Barza","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"Suppl 3","key":"10.1016\/j.mcna.2006.06.007_bib65","first-page":"S73","article-title":"Select findings and conclusions","volume":"34","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"7159","key":"10.1016\/j.mcna.2006.06.007_bib66","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/bmj.317.7159.651","article-title":"Surveillance of antimicrobial resistance\u2014an international perspective","volume":"317","author":"Williams","year":"1998","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.mcna.2006.06.007_bib67","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/qjmed\/92.5.287","article-title":"Antibiotic prescribing\u2014are there lessons for physicians?","volume":"92","author":"Nathwani","year":"1999","journal-title":"QJM"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712506000642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712506000642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T17:40:23Z","timestamp":1587318023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712506000642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":67,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0025712506000642"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2006.06.007","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}